Quick Takeaways
- Leonite Fund I, LP filed SCHEDULE 13G for HELIUS MEDICAL TECHNOLOGIES, INC. Common Shares, $0.001 par value per share (HSDT).
- Disclosed ownership: 5.2%.
- Date of event: 05 Jun 2025.
Leonite Fund I, LP - 05 Jun 2025 SCHEDULE 13G Report for HELIUS MEDICAL TECHNOLOGIES, INC. Common Shares, $0.001 par value per share (HSDT)
- Filing Manager
- Leonite Fund I, LP
- Reporting Manager
- Leonite Fund I, LP
- Symbol
- HSDT
- Shares outstanding
- 3,135,673 shares
- Disclosed Ownership
- 163,055 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Jun 2025, 16:39:05 UTC
- Date of event
- 05 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Leonite Fund I, LP disclosed 5.2% ownership in HELIUS MEDICAL TECHNOLOGIES, INC. Common Shares, $0.001 par value per share (HSDT) on 05 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Jun 2025, 16:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Leonite Fund I, LP | 5.2% | 163,055 | 163,055 | 0 | Avi Geller | Chief Investment Officer | |
| Geller Avi | 5.2% | 163,055 | 163,055 | 0 | Avi Geller | an individual |